Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and Morphic Holding (MORF)
TipRanksMar 11 07:30 ET
Morphic Holding: A Strong Buy on Robust Financials and Promising Clinical Trials
TipRanksMar 11 07:09 ET
Morphic Holding Analyst Ratings
BenzingaMar 8 12:15 ET
Morphic Holding: Strong Financials and Promising Clinical Trials Reinforce Buy Rating
TipRanksMar 8 07:55 ET
Analysts Offer Insights on Healthcare Companies: Morphic Holding (MORF) and Vertex Pharmaceuticals (VRTX)
TipRanksFeb 26 20:50 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Celldex (CLDX), Abbott Labs (ABT) and Morphic Holding (MORF)
TipRanksFeb 26 06:30 ET
Morphic Holding's Buy Rating Affirmed on Strong Clinical and Financial Prospects
TipRanksFeb 23 05:59 ET
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR) and Morphic Holding (MORF)
TipRanksFeb 22 15:20 ET
BTIG Remains a Hold on Morphic Holding (MORF)
TipRanksJan 2 09:34 ET
Morphic Holding Analyst Ratings
BenzingaDec 8, 2023 07:44 ET
RBC Cuts Price Target on Morphic Holding to $76 From $80, Keeps Outperform, Speculative Risk
MT NewswiresNov 6, 2023 08:05 ET
Promising Clinical Progress and Future Trials Reinforce Buy Rating for Morphic Holding's Stock (MORF)
TipRanksNov 6, 2023 07:58 ET
Seigerman Recommends Buy for Morphic Holding Amid Solid Financial Position, Successful Clinical Trials, and Potential Future Catalysts
TipRanksNov 6, 2023 07:46 ET
Analysts Offer Insights on Technology Companies: Morphic Holding (MORF), GoDaddy (GDDY) and Veeva Systems (VEEV)
TipRanksNov 6, 2023 07:14 ET
BTIG Remains a Hold on Morphic Holding (MORF)
TipRanksNov 6, 2023 02:01 ET
Promising Clinical Progress and Solid Financial Positioning Bolster Buy Rating for Morphic Holding
TipRanksNov 5, 2023 20:25 ET
Analysts Offer Insights on Technology Companies: Coursera (COUR), Intel (INTC) and Morphic Holding (MORF)
TipRanksOct 27, 2023 07:42 ET
Stifel Nicolaus Sticks to Their Hold Rating for Morphic Holding (MORF)
TipRanksOct 15, 2023 22:05 ET
Analysts Conflicted on These Technology Names: Infosys (INFY), Sunny Optical Technology (Group) Co (OtherSNPTF) and Morphic Holding (MORF)
TipRanksOct 13, 2023 07:20 ET
BMO Capital Maintains Outperform on Morphic Holding, Lowers Price Target to $52
BenzingaSep 28, 2023 08:29 ET
No Data
No Data